Massachusetts Financial Services Portfolio holdings
Massachusetts Financial Services (MFS), founded in 1924 and headquartered in Boston, Massachusetts, is a pioneering investment management firm credited with launching the first U.S. mutual fund, the Massachusetts Investors Trust. Managing hundreds of billions in assets, MFS offers a wide range of actively managed investment products, including equity, fixed-income, and balanced funds, serving institutional investors, financial advisors, and individuals globally. Known for its disciplined, research-driven approach, the firm emphasizes long-term value creation through fundamental analysis and a collaborative team structure, avoiding short-term market trends. With a legacy of innovation and a strong global presence, MFS remains a respected name in the asset management industry, balancing tradition with a focus on sustainable, client-centric investing.
Top Buys
| 1 |
Chevron
CVX
|
$686M |
| 2 |
RTX Corp
RTX
|
$583M |
| 3 |
Elevance Health
ELV
|
$467M |
| 4 |
TransUnion
TRU
|
$411M |
| 5 |
AbbVie
ABBV
|
$370M |
Top Sells
| 1 |
Thermo Fisher Scientific
TMO
|
$1.18B |
| 2 |
HES
Hess
HES
|
$564M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$522M |
| 4 |
Sherwin-Williams
SHW
|
$440M |
| 5 |
Microsoft
MSFT
|
$428M |
Sector Composition
| 1 | Technology | 21.5% |
| 2 | Financials | 18.86% |
| 3 | Healthcare | 13.08% |
| 4 | Industrials | 12.95% |
| 5 | Communication Services | 6.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Progressive
PGR
$144B
| $2.38B | 0.77% |
14,935,652
+520,742
| +4% | +$82.9M |
|
27
Willis Towers Watson
WTW
$31.7B
| $2.33B | 0.75% |
9,670,510
-276,295
| -3% | -$66.6M |
|
28
McKesson
MCK
$86B
| $2.33B | 0.75% |
5,024,612
-124,182
| -2% | -$57.5M |
|
29
Marsh & McLennan
MMC
$101B
| $2.29B | 0.74% |
12,110,217
-249,516
| -2% | -$47.3M |
|
30
Chubb
CB
$110B
| $2.28B | 0.74% |
10,102,563
-1,132,106
| -10% | -$256M |
|
|
31
Thermo Fisher Scientific
TMO
$184B
| $2.22B | 0.72% |
4,180,285
-2,226,776
| -35% | -$1.18B |
|
32
Prologis
PLD
$103B
| $2.19B | 0.71% |
16,435,675
-83,649
| -0.5% | -$11.2M |
|
33
Charles Schwab
SCHW
$174B
| $2.13B | 0.69% |
30,994,967
+1,219,015
| +4% | +$83.9M |
|
34
Canadian National Railway
CNI
$60.3B
| $2.09B | 0.68% |
16,644,360
-192,235
| -1% | -$24.2M |
|
35
NXP Semiconductors
NXPI
$58.7B
| $2.02B | 0.65% |
8,781,206
-357,578
| -4% | -$82.1M |
|
36
Goldman Sachs
GS
$221B
| $2B | 0.65% |
5,195,203
+27,524
| +0.5% | +$10.6M |
|
37
Pfizer
PFE
$142B
| $1.97B | 0.64% |
68,506,441
+8,298,920
| +14% | +$239M |
|
38
American Express
AXP
$230B
| $1.97B | 0.64% |
10,502,519
-767,251
| -7% | -$144M |
|
39
KLA
KLAC
$112B
| $1.95B | 0.63% |
3,354,893
+6,164
| +0.2% | +$3.58M |
|
40
General Dynamics
GD
$87.3B
| $1.93B | 0.62% |
7,417,488
-386,398
| -5% | -$100M |
|
41
Morgan Stanley
MS
$238B
| $1.88B | 0.61% |
20,197,232
+575,114
| +3% | +$53.6M |
|
42
Eli Lilly
LLY
$659B
| $1.87B | 0.6% |
3,213,357
-97,502
| -3% | -$56.8M |
|
43
Northrop Grumman
NOC
$84.4B
| $1.86B | 0.6% |
3,965,139
-133,699
| -3% | -$62.6M |
|
44
Agilent Technologies
A
$35.6B
| $1.84B | 0.59% |
13,246,489
+2,170,219
| +20% | +$302M |
|
45
Duke Energy
DUK
$94.8B
| $1.81B | 0.59% |
18,699,484
-584,412
| -3% | -$56.7M |
|
46
Southern Company
SO
$101B
| $1.78B | 0.58% |
25,419,616
-684,281
| -3% | -$48M |
|
47
Lowe's Companies
LOW
$145B
| $1.77B | 0.57% |
7,968,132
-84,459
| -1% | -$18.8M |
|
48
Vulcan Materials
VMC
$38.6B
| $1.73B | 0.56% |
7,640,884
-103,259
| -1% | -$23.4M |
|
49
DuPont de Nemours
DD
$31.7B
| $1.7B | 0.55% |
22,155,608
-704,302
| -3% | -$54.2M |
|
50
Verisk Analytics
VRSK
$37B
| $1.64B | 0.53% |
6,859,562
-663,629
| -9% | -$159M |
|